title: Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy.
abstract: OBJECTIVE
  Few groups have examined satisfaction after prostate cancer treatment. We determined 1) predictors of satisfaction between 3 months and 2 years after open radical retropubic prostatectomy, and 2) whether these factors are time dependent.
  
  
  METHODS
  This prospective cohort study included 1,542 men who underwent radical retropubic prostatectomy from October 2000 to July 2008. The primary outcome was satisfaction self-assessed at 3, 6, 12 and 24 months. We used multivariate logistic regression and repeated measures analysis to determine predictors of satisfaction, adjusting for demographic and clinical characteristics.
  
  
  RESULTS
  Median followup was 24 months. About 93% of the men were satisfied. On multivariate analysis men were significantly less satisfied at 3 months when the urinary catheter was indwelling for 3 weeks or greater (OR 0.23, 95% CI 0.10-0.54), or they required intervention for anastomotic stricture (OR 0.23, 95% CI 0.11-0.49) or experienced 4-point or greater worsening in American Urological Association symptom score (OR 0.26, 95% CI 0.13-0.49). At 6 months worsening urinary function (OR 0.34, 95% CI 0.13-0.88) and biochemical failure (OR 0.15, 95% CI 0.05-0.43) were significantly associated with satisfaction. Worsening sexual function became significant at 12 and 24 months. These associations were confirmed on repeated measures analysis.
  
  
  CONCLUSIONS
  Most men were satisfied after radical retropubic prostatectomy. Satisfaction determinants showed a nonsignificant trend toward time dependence. Postoperative factors, such as the duration of indwelling Foley catheterization, were associated with short-term satisfaction while sexual and urinary function, and biochemical failure were associated with long-term satisfaction. Based on high satisfaction rates open radical retropubic prostatectomy is an excellent treatment for prostate cancer.
authors.affiliation: Department of Urology, New York University School of Medicine, New York, New York, USA.
authors.forename: Nitya E
authors.initials: NE
authors.lastname: Abraham
authors.forename: Danil V
authors.initials: DV
authors.lastname: Makarov
authors.forename: Juliana
authors.initials: J
authors.lastname: Laze
authors.forename: Elina
authors.initials: E
authors.lastname: Stefanovics
authors.forename: Rani
authors.initials: R
authors.lastname: Desai
authors.forename: Herbert
authors.initials: H
authors.lastname: Lepor
mesh_terms: D000328:Adult; D000368:Aged; D005544:Forecasting; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D018802:Patient-Centered Care; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome